Overview A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients Status: Completed Trial end date: 2019-03-14 Target enrollment: Participant gender: Summary A Clinical Trial to Evaluate the Pharmacodynamics/Pharmacokinetics and Safety of LY03003 in Early PD Patients Phase: Phase 1 Details Lead Sponsor: Luye Pharma Group Ltd.